M.I.TECH Co.Ltd

179290 · KQ · Healthcare / Medical Instruments & Supplies

3,845.00KRW-10.00 (-0.26%)

Price History

Full chart

Market Stats

Previous Close3,855.00

Open3,845.00

Day Range3,785.00 – 3,895.00

52-Week Range4,000.00 – 7,860.00

Volume40.42K

Market Cap152.93B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield2.57%

Beta-0.08

50-Day Avg4,948.60

200-Day Avg5,899.68

About

M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective component in non-invasive way and instantly check skin condition before and after treatment. The company was formerly known as Solco Intermed Co., Ltd. and changed its name to M.I.TECH Co.,Ltd in March 1999. M.I.TECH Co.,Ltd was founded in 1991 and is headquartered in Pyeongtaek-Si, South Korea. M.I.TECH Co.,Ltd operates as a subsidiary of Synergy Innovation Co., Ltd.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Mahtthew J. Han
Employees178
Headquarters174, Habuk 2-gil, Pyeongtaek-Si, South Korea, 17706, Korea
Websitehttps://www.mitech.co.kr

Leadership

Mr. Mahtthew J. HanChief Executive Officer and President

Financials

Income Statement

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	12.65B	16.37B	22.54B	29.60B	32.65B	40.20B	50.26B	56.22B	46.39B	53.75B	67.15B
Growth (%)	-	+29.41%	+37.71%	+31.31%	+10.32%	+23.12%	+25.01%	+11.86%	-17.49%	+15.88%	+24.93%
Cost of Revenue	5.80B	7.49B	12.26B	15.23B	17.95B	21.33B	24.29B	22.52B	21.08B	22.84B	29.03B
Gross Profit	6.85B	8.88B	10.28B	14.37B	14.71B	18.87B	25.97B	33.70B	25.31B	30.91B	38.12B
Gross Margin	54.15%	54.27%	45.60%	48.56%	45.04%	46.95%	51.67%	59.95%	54.56%	57.51%	56.77%
Operating Expense	5.93B	6.77B	8.56B	9.31B	11.45B	12.98B	13.04B	11.42B	11.25B	13.33B	17.45B
Operating Income	924.04M	2.11B	1.72B	5.06B	3.26B	5.89B	12.93B	22.29B	14.07B	17.58B	20.67B
Operating Margin	7.31%	12.92%	7.64%	17.09%	9.97%	14.66%	25.72%	39.64%	30.32%	32.71%	30.79%
EBITDA	-	-	-	-	-	-	-	28.04B	17.25B	24.25B	27.53B
EBITDA Margin	-	-	-	-	-	-	-	49.87%	37.18%	45.10%	41.00%
Net Income	600.15M	2.01B	2.05B	390.12M	3.66B	6.68B	12.25B	19.15B	12.80B	18.29B	20.33B
Net Income Margin	4.74%	12.29%	9.10%	1.32%	11.22%	16.62%	24.36%	34.06%	27.59%	34.02%	30.28%
R&D	-	2.30B	1.96B	2.12B	3.04B	3.85B	4.18B	4.40B	3.66B	2.85B	4.86B
R&D as % of Total Revenue	-	14.03%	8.70%	7.17%	9.30%	9.59%	8.32%	7.82%	7.90%	5.31%	7.24%
Interest Expense	0	0	0	0	75.81M	132.06M	137.85M	140.96M	73.60M	42.14M	195.13M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.23%	0.33%	0.27%	0.25%	0.16%	0.08%	0.29%

Balance Sheet

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	17.20B	20.40B	29.66B	49.26B	57.31B	68.08B	78.53B	94.05B	98.84B	118.53B	141.84B
Total Liabilities	2.50B	3.77B	10.99B	4.49B	9.06B	12.68B	13.76B	10.50B	5.90B	9.70B	15.91B
Total Equity	14.71B	16.63B	18.67B	44.77B	48.25B	55.40B	64.76B	83.55B	92.94B	108.83B	125.93B
Cash	411.64M	828.37M	6.61B	11.59B	10.29B	13.29B	16.03B	5.94B	19.05B	56.26B	39.68B
Total Debt	-	-	4.20B	-	3.59B	6.01B	-	-	-	-	-

Cash Flow

Currency: KRW	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-677.68M	2.78B	963.43M	2.04B	3.11B	3.90B	16.52B	8.59B	17.81B	23.66B	14.87B
Investing Cash Flow	-267.54M	-2.37B	-120.61M	-13.10B	-5.46B	-3.35B	-9.74B	-13.32B	856.62M	15.68B	-
Financing Cash Flow	-105.76K	5.00B	5.00B	16.07B	1.12B	2.58B	-4.03B	-5.19B	-5.40B	-2.79B	-
Capital Expenditure	1.32B	1.02B	826.56M	1.18B	5.25B	4.44B	1.24B	679.08M	947.96M	1.16B	4.96B
Free Cash Flow	-	-	-	-	-	704.27M	15.28B	7.91B	16.86B	22.50B	9.91B
Dividends Paid	-	1.52B	1.52B	1.52B	1.52B	1.52B	1.87B	2.49B	3.85B	2.58B	3.24B
FCF to OCF	-	-	-	-	-	18.04%	92.48%	92.10%	94.68%	95.10%	66.64%
Dividend Paid to FCF	-	-	-	-	-	215.98%	12.24%	31.47%	22.83%	11.47%	32.65%

Earnings

Report Date	Aug 14, 2018	May 14, 2019	Aug 14, 2019	Nov 13, 2019	Feb 23, 2020	May 14, 2020	Aug 12, 2020	Nov 12, 2020	Feb 23, 2021	May 13, 2021	Aug 12, 2021	Nov 11, 2021	Feb 20, 2022	May 13, 2022	Aug 11, 2022	Nov 10, 2022	Feb 26, 2023	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	156.49	-	-	-	-	-	-	-
EPS Actual	67.81	40.33	36.22	24.20	19.68	64.11	68.52	38.37	54.50	74.13	97.52	106.95	101.93	101.17	148.00	185.00	154.13	154.03	58.04	32.23	151.93	173.85	148.22	135.00	109.18	179.43	137.71	152.74	158.38	149.19	180.06
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13.73%	-	-	-	-	-	-	-
Timing	Pre-market	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap152.93B

Enterprise Value87.26B

Trailing P/E0.00

Forward P/E0.00

Price / Sales2.16

Price / Book1.10

Revenue (TTM)70.72B

Gross Profit (TTM)40.47B

EBITDA23.68B

Profit Margin29.31%

Operating Margin29.37%

Return on Equity16.42%

Return on Assets9.93%

Shares Outstanding32.37M

Shares Float10.52M

Beta-0.08

Dividend Yield2.57%

Dividend Rate120.00

Payout Ratio18.74%

Dividends

20251×

120.00Dec 29, 2025

20241×

100.00Dec 27, 2024

20231×

80.00Dec 27, 2023

20221×

120.00Dec 28, 2022

20211×

80.00Dec 29, 2021

20201×

60.00Dec 29, 2020

20191×

50.00Dec 27, 2019

20181×

50.00Dec 27, 2018